Format

Send to

Choose Destination
Curr Opin Endocrinol Diabetes Obes. 2017 Oct;24(5):332-336. doi: 10.1097/MED.0000000000000359.

The thyroid cancer epidemic, 2017 perspective.

Author information

1
aDepartment of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York City, New York bDepartment of Veterans Affairs Medical Center, VA Outcomes Group, White River Junction, Vermont; Section of Otolaryngology, Geisel School of Medicine, Dartmouth College, Hanover; The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire, USA.

Abstract

PURPOSE OF REVIEW:

Thyroid cancer incidence and mortality trends have been identified as being consistent with overdiagnosis, and several recent efforts have been made to mitigate this problem.

RECENT FINDINGS:

Major guidelines for thyroid nodule management recommend against general biopsy of nodules less than 1 cm in size. Data supporting the safety of active surveillance of low-risk thyroid cancers is now recognized. Tumors previously labeled as encapsulated follicular variant papillary thyroid cancers are now recommended to be called noninvasive follicular thyroid neoplasm with papillary-like nuclear features.

SUMMARY:

Workup, diagnostic, and management of papillary thyroid cancer are changing rapidly to accommodate the recognition that many thyroid cancers are low risk and do not require aggressive, immediate intervention.

PMID:
28692457
PMCID:
PMC5864110
DOI:
10.1097/MED.0000000000000359
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center